Validated HPTLC Method to Estimate Silymarin in Marketed Herbal Formulation
1★, 1, 1, 1, 1, 1★ Corresponding author
- 1Government College of Pharmacy, Amravati, Maharashtra, INDIA.
CORRESPONDENCE
Sharada L Deore
Government College of Pharmacy, Amravati, Maharashtra, INDIA.
Received: 23-10-2020; Revised: 27-11-2020; Accepted: 19-12-2020.
Volume 11, Issue 1 · pp. 52-55 · 2021 · DOI: 10.5530/ijpi.2021.1.10
ABSTRACT
Objectives: The objective of present research work is to develop simple, rapid and accurate high performance thin layer chromatographic method for quantitative estimation of silymarin in marketed hepatoprotective formulation.Methods: The separation was performed on silica gel 60 F254 precoated TLC aluminum plates and toluene: ethyl acetate: formic acid: methanol as mobile phase. Determination and quantitation were performed by densitometric scanning at 288 nm. Validation of method is carried out as per International Conference of Harmonization (ICH) guidelines.Results: Accuracy, precision and recovery were all within the required limits.Conclusion: In conclusion, the developed HPTLC method is precise and accurate for implementation in routine quality control. The selected marketed hepatoprotective formulation contains the sufficient amount of the active ingredient which is required for its therapeutic efficiency.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Deore, S. L., Tidke, H. P., Khadabadi, S. S., Baviskar, B. A., Kide, A. A., & Shende, B. P. (2021). Validated HPTLC Method to Estimate Silymarin in Marketed Herbal Formulation. International Journal of Pharmaceutical Investigation, 11(1), 52-55. https://doi.org/10.5530/ijpi.2021.1.10
Copyright and licence
© 2021 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0
